Translational Genomics Research Institute

2020–2022 · research · R21

A novel approach for deep phenotyping the CD4 T cell response to Mycobacterium Tuberculosis

John Altin · Translational Genomics Research Institute · funded by National Institutes of Health

$255.2k

2020–2023 · cooperative agreement · U24

A scalable platform for highly-multiplexed analysis of antibody reactivity from <1uL of blood

John Altin · Translational Genomics Research Institute · funded by National Institutes of Health

$61.3kAdvanced Biosensing Techniques and Applications

2019–2023 · research · R01

Combining genome, function, and phenotype to define the cell type specific gene regulatory architecture of idiopathic pulmonary fibrosis

Nicholas Eli Banovich · Translational Genomics Research Institute · funded by National Institutes of Health

$701.3kInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

2019–2023 · research · R01

Combining genome, function, and phenotype to define the cell type specific gene regulatory architecture of idiopathic pulmonary fibrosis

Nicholas Eli Banovich · Translational Genomics Research Institute · funded by National Institutes of Health

$753.3kInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

2019–2024 · research · R01

Profiling extracellular vesicle cargo in obesity and type 2 diabetes

Johanna K Distefano · Translational Genomics Research Institute · funded by National Institutes of Health

$712.6kExtracellular vesicles in disease

2019–2025 · research · R01

Profiling extracellular vesicle cargo in obesity and type 2 diabetes

Johanna K Distefano · Translational Genomics Research Institute · funded by National Institutes of Health

$753.4kExtracellular vesicles in disease

2019–2023 · research · R01

Combining genome, function, and phenotype to define the cell type specific gene regulatory architecture of idiopathic pulmonary fibrosis

Nicholas Eli Banovich · Translational Genomics Research Institute · funded by National Institutes of Health

$710.8kInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

2019–2025 · cooperative agreement · UH3

Integrative Cross Species Analysis for Longevity Drug Target Identification

Richard A Miller · Translational Genomics Research Institute · funded by National Institutes of Health

$390kGenetics, Aging, and Longevity in Model Organisms

2019 · research · Biomarkers of Protein Handling/Autophagy, Exosomes and Lipid

Extracellular Vesicles from Urine as Non-invasive Biomarkers

Kendall Van Keuren-Jensen · Translational Genomics Research Institute · funded by Michael J. Fox Foundation for Parkinson's Research

2019–2023 · research · R01

Combining genome, function, and phenotype to define the cell type specific gene regulatory architecture of idiopathic pulmonary fibrosis

Nicholas Eli Banovich · Translational Genomics Research Institute · funded by National Institutes of Health

$701.3kInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

2019–2025 · cooperative agreement · UH3

Integrative Omics to enhance therapeutics development for healthy aging

Richard A Miller · Translational Genomics Research Institute · funded by National Institutes of Health

$878.3k

2019–2021 · cooperative agreement · UH2

Integrative Omics to enhance therapeutics development for healthy aging

Daniel Spencer Evans · Translational Genomics Research Institute · funded by National Institutes of Health

$599.1k

2019–2020 · cooperative agreement · U01

Pre-analytical factors affecting ctDNA analysis in early and locally advanced breast cancer

Muhammed Murtaza · Translational Genomics Research Institute · funded by National Institutes of Health

$419.1kCancer Genomics and Diagnostics

2019–2021 · cooperative agreement · UH2

Cross-Species Analysis to Identify Conserve Longevity-Related Pathways and Putative Drug Targets

Daniel Spencer Evans · Translational Genomics Research Institute · funded by National Institutes of Health

$173kGenetics, Aging, and Longevity in Model Organisms

2019–2025 · research · R01

Profiling extracellular vesicle cargo in obesity and type 2 diabetes

Johanna K Distefano · Translational Genomics Research Institute · funded by National Institutes of Health

$711.6kExtracellular vesicles in disease

2019–2021 · career development · K99

Characterization of the role of super-enhancers in ovarian cancer treatment response

Jessica Diane Lang · Translational Genomics Research Institute · funded by National Institutes of Health

$54k

2019–2021 · career development · K99

Characterization of the role of super-enhancers in ovarian cancer treatment response

Jessica Diane Lang · Translational Genomics Research Institute · funded by National Institutes of Health

$84.4k

2019–2028 · research · R01

Spatiotemporal genomic regulation of disease initiation and progression in pulmonary fibrosis

Nicholas Eli Banovich · Translational Genomics Research Institute · funded by National Institutes of Health

$847.3kInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

2019–2025 · research · R01

Profiling extracellular vesicle cargo in obesity and type 2 diabetes

Johanna K Distefano · Translational Genomics Research Institute · funded by National Institutes of Health

$763kExtracellular vesicles in disease

2019–2024 · cooperative agreement · UH3

Integrative Omics to enhance therapeutics development for healthy aging

Richard A Miller · Translational Genomics Research Institute · funded by National Institutes of Health

$216.5k

2019–2021 · cooperative agreement · UH2

Integrative Omics to enhance therapeutics development for healthy aging

Richard A Miller · Translational Genomics Research Institute · funded by National Institutes of Health

$603.3k

2019–2024 · cooperative agreement · UH3

Integrative Omics to enhance therapeutics development for healthy aging

Richard A Miller · Translational Genomics Research Institute · funded by National Institutes of Health

$890.1k

2019–2021 · career development · K99

Characterization of the role of super-enhancers in ovarian cancer treatment response

Jessica Diane Lang · Translational Genomics Research Institute · funded by National Institutes of Health

$84.4k

2019–2024 · cooperative agreement · U01

Pre-analytical factors affecting ctDNA analysis in early and locally advanced breast cancer

Muhammed Murtaza · Translational Genomics Research Institute · funded by National Institutes of Health

$440k

2019–2024 · research · R01

Combining genome, function, and phenotype to define the cell type specific gene regulatory architecture of idiopathic pulmonary fibrosis

Nicholas Eli Banovich · Translational Genomics Research Institute · funded by National Institutes of Health

$701.3kInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

2019–2024 · cooperative agreement · UH3

Integrative Omics to enhance therapeutics development for healthy aging

Richard A Miller · Translational Genomics Research Institute · funded by National Institutes of Health

$884.2k

2019–2025 · research · R01

Profiling extracellular vesicle cargo in obesity and type 2 diabetes

Johanna K Distefano · Translational Genomics Research Institute · funded by National Institutes of Health

$722.4kExtracellular vesicles in disease

2019–2028 · research · R01

Spatiotemporal genomic regulation of disease initiation and progression in pulmonary fibrosis

Nicholas Eli Banovich · Translational Genomics Research Institute · funded by National Institutes of Health

$824.3k

2019–2021 · cooperative agreement · UH2

ConProject-001

Daniel Spencer Evans · Translational Genomics Research Institute · funded by National Institutes of Health

2018–2020 · research · R01

Individualized monitoring of treatment response and resistance in patients with metastatic melanoma

Muhammed Murtaza · Translational Genomics Research Institute · funded by National Institutes of Health

$415.3kCutaneous Melanoma Detection and Management

2018–2024 · research · R00

Genetic and Epigenetic Strategies for the Acquisition of Telomere Maintenance in Human Cancer Cells

Floris Barthel · Translational Genomics Research Institute · funded by National Institutes of Health

$249kTelomeres, Telomerase, and Senescence

2018–2024 · research · R00

Genetic and Epigenetic Strategies for the Acquisition of Telomere Maintenance in Human Cancer Cells

Floris Barthel · Translational Genomics Research Institute · funded by National Institutes of Health

$244kTelomeres, Telomerase, and Senescence

2018–2024 · research · R00

Genetic and Epigenetic Strategies for the Acquisition of Telomere Maintenance in Human Cancer Cells

Floris Barthel · Translational Genomics Research Institute · funded by National Institutes of Health

$244kTelomeres, Telomerase, and Senescence

2018–2023 · research · R01

Individualized monitoring of treatment response and resistance in patients with metastatic melanoma

Muhammed Murtaza · Translational Genomics Research Institute · funded by National Institutes of Health

$402.9kCutaneous Melanoma Detection and Management

2018–2023 · research · R01

Individualized monitoring of treatment response and resistance in patients with metastatic melanoma

Muhammed Murtaza · Translational Genomics Research Institute · funded by National Institutes of Health

$457.7k

2016–2020 · research · R01

Epigenetic markers of severity in nonalcoholic fatty liver disease

Johanna K Distefano · Translational Genomics Research Institute · funded by National Institutes of Health

$118.1kLiver Disease Diagnosis and Treatment

2016–2022 · research · R01

Epigenetic markers of severity in nonalcoholic fatty liver disease

Johanna K Distefano · Translational Genomics Research Institute · funded by National Institutes of Health

$553.9kLiver Disease Diagnosis and Treatment

2016–2021 · research · R01

Epigenetic markers of severity in nonalcoholic fatty liver disease

Johanna K Distefano · Translational Genomics Research Institute · funded by National Institutes of Health

$715.6kLiver Disease Diagnosis and Treatment

2016–2021 · research · R01

Epigenetic markers of severity in nonalcoholic fatty liver disease

Johanna K Distefano · Translational Genomics Research Institute · funded by National Institutes of Health

$560.5kLiver Disease Diagnosis and Treatment

2016 · research · R01

TROY HTS Compound Screening

Nhan L Tran · Translational Genomics Research Institute · funded by National Institutes of Health

$22.9k